Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Treatment of Major Depression
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the molecular mechanisms and treatment strategies for depression, with a particular emphasis on antidepressant medications, ketamine, NMDA receptor antagonists, and neurobiological pathways. It covers topics such as treatment-resistant depression, glutamate signaling, cognitive impairment, and synaptic plasticity. The papers also discuss clinical guidelines and the evaluation of outcomes for various treatment approaches.
422
Works
IDs:OpenAlex
How has Treatment of Major Depression's publication output changed over time?
ScholarIQpublication output · 2003–2019
Output grew100% over the shown period — from 1 works in 2003 to 2 in 2019.
1
2
2
1
1
1
2
1
1
2
2003200520062007200920102011201520172019
What are the most-cited papers on Treatment of Major Depression?
ScholarIQmost cited works
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson, Nancy E. Brutsché, Rezvan Ameli, David A. Luckenbaugh, Dennis S. Charney, Husseini K. Manji
S126359496. 20063,782 CitationsOPEN ACCESS
Antidepressant Drug Effects and Depression Severity
Jay C. Fournier, Robert J. DeRubeis, Steven D. Hollon, Sona Dimidjian, Jay D. Amsterdam, Richard C. Shelton, Jan Fawcett
JAMA. 20102,017 Citations
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani, Toshi A. Furukawa, Georgia Salanti, John Geddes, Julian P. T. Higgins, Rachel Churchill, Norio Watanabe, Atsuo Nakagawa, Ichiro M Omori, Hugh McGuire, Michele Tansella, Corrado Barbui
The Lancet. 20091,660 Citations
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.
Sona Dimidjian, Steven D. Hollon, Keith S. Dobson, Karen B. Schmaling, Robert J. Kohlenberg, Michael E. Addis, Robert Gallop, Joseph B. McGlinchey, David K. Markley, Jackie K. Gollan, David C. Atkins, David L. Dünner, Neil S. Jacobson
S118719888. 20061,622 Citations
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
Robert J. DeRubeis, Steven D. Hollon, Jay D. Amsterdam, Richard C. Shelton, Paula R. Young, Ronald M. Salomon, John P. O’Reardon, Margaret L. Lovett, Madeline Gladis, Laurel L. Brown, Robert Gallop
S126359496. 2005995 Citations
Where is Treatment of Major Depression research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Treatment of Major Depression is open access?
ScholarIQopen access share
40%OPEN ACCESS
Gold
0%
Green
7%
Hybrid
7%
Bronze
27%
Closed
60%
Related on ScholarIQ
The PHQ-9
Paper
The Patient Health Questionnaire-2
Paper
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Paper
The PHQ-8 as a measure of current depression in the general population
Paper
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
Paper
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4
Paper